NeuroPace Chief Legal Officer Irina Ridley resigns; transition agreement with consulting and severance

NeuroPace Inc

Irina Ridley resigns as CLO and Corporate Secretary; last day of employment is March 6, 2024.
Transition Agreement provides base salary, benefits, and vesting through Separation Date; 2023 bonus eligible.
Post-separation consulting period through Dec 31, 2024; initial stock option continues vesting.
Severance includes 12 months base salary continuation and up to 12 months COBRA reimbursement.
One-time cash payment of $32,226 upon signing general release of claims.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Irina Ridley

Chief Legal Officer and Corporate Secretary

NPCE · NeuroPace Inc

Effective: 2024-03-06
Filed: February 7, 2024, 6:59 PM ET

On February 1, 2024, Irina Ridley notified NeuroPace, Inc. (the “Company”) that she was resigning from her role as the Company’s Chief Legal Officer and Corporate Secretary and that her last day of employment will be March 6, 2024 (the “Separation Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Irina Ridley resigned as Chief Legal Officer and Corporate Secretary at NeuroPace Inc.

Action: resigned
Role: Chief Legal Officer and Corporate Secretary

Exact text from the filing

On February 1, 2024, Irina Ridley notified NeuroPace, Inc. (the “Company”) that she was resigning from her role as the Company’s Chief Legal Officer and Corporate Secretary and that her last day of employment will be March 6, 2024 (the “Separation Date”).

View on SEC.gov

NeuroPace Inc filing history →

Source: SEC EDGAR

accession 0001193125-24-026756

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.